Cargando…
199. Short versus Extended Antibiotic Treatment with a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients with Fever of Unknown Origin: A Randomized Multicenter Noninferiority Trial
BACKGROUND: In hematology patients with high risk neutropenia due to intensive chemotherapy the optimal antibiotic treatment duration for fever of unknown origin (FUO) is unknown. Early antibiotic discontinuation has been advocated to reduce unnecessary exposure to broad-spectrum antibiotics, but th...
Autores principales: | de Jonge, Nick A, Sikkens, Jonne, Zweegman, Sonja, Beeker, Aart, Ypma, Paula, Herbers, Alexandra, Vasmel, Wies, de Kreuk, Arne, Coenen, Juleon, Lissenberg-Witte, Birgit, Budding, Andries, Kramer, Mark, Van Agtmael, Michiel, Janssen, Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777043/ http://dx.doi.org/10.1093/ofid/ofaa439.509 |
Ejemplares similares
-
Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011) -
Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018) -
Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)